T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Becton Dickinson
BDX
|
+$3.46B |
| 2 |
UnitedHealth
UNH
|
+$2.79B |
| 3 |
Salesforce
CRM
|
+$2.38B |
| 4 |
Sherwin-Williams
SHW
|
+$1.41B |
| 5 |
Philip Morris
PM
|
+$1.34B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$4.44B |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$2.97B |
| 3 |
GE Aerospace
GE
|
+$2.3B |
| 4 |
HCA Healthcare
HCA
|
+$2.17B |
| 5 |
American International
AIG
|
+$1.68B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.68% |
| 2 | Healthcare | 19.49% |
| 3 | Consumer Discretionary | 13.07% |
| 4 | Financials | 11.17% |
| 5 | Communication Services | 8.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
651
Replimune Group
REPL
$1.46B
| $103M | 0.01% |
5,882,531
-140,229
| -2% | -$2.3M |
|
652
First Industrial Realty Trust
FR
$8.42B
| $102M | 0.01% |
2,151,789
+24,329
| +1% | +$1.33M |
|
653
Towne Bank
TOWN
$3.5B
| $102M | 0.01% |
3,760,698
-84,465
| -2% | -$2.41M |
|
|
BFS
654
Saul Centers
BFS
$854M
| $102M | 0.01% |
2,162,538
+3,838
| +0.2% | +$189K |
|
655
UiPath
PATH
$7.87B
| $101M | 0.01% |
5,573,624
-16,911,093
| -75% | -$316M |
|
656
AZZ Inc
AZZ
$4.54B
| $101M | 0.01% |
2,475,782
-144
| -0% | -$6.46K |
|
657
Alamo Group
ALG
$2.01B
| $101M | 0.01% |
864,063
+36,290
| +4% | +$4.45M |
|
658
Alignment Healthcare
ALHC
$2.83B
| $100M | 0.01% |
8,805,887
+236,652
| +3% | +$2.5M |
|
659
Tetra Tech
TTEK
$9.11B
| $100M | 0.01% |
3,671,740
+16,410
| +0.4% | +$450K |
|
|
NEX
660
DELISTED
NexTier Oilfield Solutions Inc.
NEX
| $100M | 0.01% |
10,520,192
-3,062,343
| -23% | -$32.1M |
|
661
Sociedad Química y Minera de Chile
SQM
$20.7B
| $99.8M | 0.01% |
1,195,008
+466,002
| +64% | +$41M |
|
662
Federal Signal
FSS
$7.7B
| $99.7M | 0.01% |
2,799,397
+148,657
| +6% | +$5.11M |
|
|
GBT
663
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $99.3M | 0.01% |
3,106,801
-74,498
| -2% | -$2.18M |
|
|
SKX
664
DELISTED
Skechers
SKX
| $99.1M | 0.01% |
2,784,301
+165,147
| +6% | +$6.34M |
|
665
Royalty Pharma
RPRX
$26.2B
| $98.9M | 0.01% |
2,352,542
+91,343
| +4% | +$3.74M |
|
666
Palo Alto Networks
PANW
$319B
| $98.9M | 0.01% |
1,201,068
-74,964
| -6% | -$6.65M |
|
|
ELME
667
Elme Communities
ELME
$144M
| $98.8M | 0.01% |
4,638,480
+7,505
| +0.2% | +$178K |
|
|
ACC
668
DELISTED
American Campus Communities, Inc.
ACC
| $98.7M | 0.01% |
1,530,787
-6,205,678
| -80% | -$393M |
|
669
Duolingo
DUOL
$6.38B
| $98.6M | 0.01% |
1,126,165
+966,604
| +606% | +$85.4M |
|
670
Adaptive Biotechnologies
ADPT
$3.95B
| $98.6M | 0.01% |
12,183,895
-232,472
| -2% | -$2.04M |
|
671
Truist Financial
TFC
$64.7B
| $98.2M | 0.01% |
2,069,754
-180,333
| -8% | -$8.89M |
|
672
Meritage Homes
MTH
$4.81B
| $98M | 0.01% |
2,702,274
-61,974
| -2% | -$2.47M |
|
|
AGTI
673
DELISTED
Agiliti Inc
AGTI
| $97.9M | 0.01% |
4,771,852
-122,520
| -3% | -$2.44M |
|
674
Main Street Capital
MAIN
$5.52B
| $96.4M | 0.01% |
2,501,374
+1,788,197
| +251% | +$69.9M |
|
675
Cognizant
CTSH
$26.1B
| $95.9M | 0.01% |
1,421,675
-6,178,816
| -81% | -$473M |
|
Similar funds
T. Rowe Price Associates's Q2 2022 Portfolio in Review
As of Q2 2022, T. Rowe Price Associates held 3,063 positions worth $791B, down 20% from $992B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
T. Rowe Price Associates's Q2 2022 filing shows 88 new, 1,490 increased, 1,207 reduced and 101 closed positions. Its largest new stake was ESAB: 6,073,363 shares worth $266M. The largest sale was Meta Platforms (Facebook), an estimated $4.44B.
By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q2 2022 buy was ESAB: 6,073,363 shares worth $266M.
- T. Rowe Price Associates added most to Becton Dickinson in Q2 2022, an estimated $3.46B increase.
- T. Rowe Price Associates's biggest Q2 2022 reduction was Meta Platforms (Facebook), cutting an estimated $4.44B.
- T. Rowe Price Associates fully exited Ortho Clinical Diagnostics Holdings plc Ordinary Shares in Q2 2022, selling an estimated $364M.
- T. Rowe Price Associates's ten largest holdings make up 26% of its $791B portfolio in Q2 2022.
- T. Rowe Price Associates opened 88 new positions and closed 101 in Q2 2022.
- T. Rowe Price Associates's portfolio value fell 20% quarter-over-quarter to $791B.
Based on T. Rowe Price Associates's 13F filing for Q2 2022, filed 15 Aug 2022.